Ve
Vesalius Ther
Cambridge MAFounded 202125 employees
Private CapbiotechPrivateNeurology
Platform: Somatic Mosaic
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
2
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capifutibatinib | VES-4101 | Phase 2/3 | 2 | SOS1 | CSUMM | ||
| VES-7360 | VES-7360 | Approved | 1 | MET | LNEwing Sarcoma | ||
| Tixasotorasib | VES-4600 | Approved | 2 | VEGF | Wet AMD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)